As the globe faces a rise in antibiotic-resistant bacteria—making traditional ... now better known for its applications in medicine and biotechnology. CRISPR systems in general act as "molecular ...

Flightpath Biosciences, Inc., a clinical stage biotechnology company focused on the development of precision therapeutics targeting bacterial ...

Only one antibiotic – Sulbactam-durlobactam (brand name: Xacduro) – was effective against CRAB. Approved by US regulators in ...

Basilea already secured $29 million to develop its antifungals fosmanogepix and BAL2062, and the Swiss company announced this morning that it has confirmed it will also receive its next tranche of $39 ...

Doctors and scientists are hopeful that the non-antibiotic treatment could ultimately help millions of patients ...

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Chinese biotech Brii Biosciences (HKEX: 2137) has licensed its experimental antibiotic BRII-693 to domestic pharma business ...

DURHAM, NC, USA and BEIJING, China I July 3, 2025 I Brii Biosciences Limited ("Brii Bio," stock code: 2137.HK), a biotechnology company developing ...

Centre for Cellular and Molecular Platforms Thursday launched a ‘One Health AMR Challenge 2025’ in Bengaluru to support ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in ...

A group of 53 biotech leaders is expressing support for mifepristone in a letter to the FDA, urging the agency not to impose new restrictions on its use as an abortion medication and slamming a ...